Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$10.88 - $20.05 $1.63 Million - $3.01 Million
-150,067 Reduced 29.87%
352,387 $4.02 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $641,773 - $1.05 Million
39,961 Added 8.64%
502,454 $8.55 Million
Q2 2022

Aug 15, 2022

SELL
$20.49 - $39.72 $311,550 - $603,942
-15,205 Reduced 3.18%
462,493 $9.93 Million
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $2.46 Million - $4.07 Million
87,372 Added 22.38%
477,698 $17.7 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $7.14 Million - $12.7 Million
173,205 Added 79.77%
390,326 $17.8 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $2.25 Million - $3.5 Million
38,034 Added 21.24%
217,121 $13.8 Million
Q2 2021

Aug 16, 2021

SELL
$63.02 - $95.11 $25,964 - $39,185
-412 Reduced 0.23%
179,087 $16.4 Million
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $1.36 Million - $2.25 Million
-23,567 Reduced 11.61%
179,499 $12.2 Million
Q4 2020

Feb 16, 2021

SELL
$41.43 - $77.09 $2.94 Million - $5.48 Million
-71,054 Reduced 25.92%
203,066 $14.7 Million
Q3 2020

Nov 16, 2020

SELL
$30.88 - $37.94 $147,668 - $181,429
-4,782 Reduced 1.71%
274,120 $10.4 Million
Q2 2020

Aug 14, 2020

SELL
$18.95 - $35.43 $93,802 - $175,378
-4,950 Reduced 1.74%
278,902 $9.88 Million
Q1 2020

May 15, 2020

BUY
$13.94 - $28.25 $136,876 - $277,386
9,819 Added 3.58%
283,852 $6.2 Million
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $225,569 - $333,078
-11,724 Reduced 4.1%
274,033 $5.91 Million
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $5.72 Million - $11.5 Million
285,757 New
285,757 $6.46 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.26B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.